IDEXX Laboratories (IDXX) Revenue — Quarter Ended Mar 31, 2023
Revenue increased in the quarter, reversing the sequential decline seen in the prior period. The top line also grew from the same quarter one year earlier.
Key takeaway
Quarter ended Mar 31, 2023 · FY2023 Q1
Revenue increased in the quarter, reversing the sequential decline seen in the prior period. The top line also grew from the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$900.2M
Revenue reported for this quarter.
Quarter-over-quarter
+8.6%
Change from the immediately preceding quarter.
Year-over-year
+7.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2022 | $860.5M | +4.2% |
| Sep 30, 2022 | $841.7M | +3.9% |
| Dec 31, 2022 | $828.6M | +3.4% |
| Mar 31, 2023 | $900.2M | +7.6% |
Revenue performance
Reported revenue rose from the immediately preceding quarter, after two consecutive quarters of declines. Compared with the same quarter a year ago, revenue was also higher.
Quarterly comparison
The change from the prior quarter was positive, following three quarters of slowing growth. The year-over-year comparison also showed an increase, though the filing context does not attribute any specific cause.
What to watch
No specific watch item is indicated in the supplied filing context for this quarter.